Farxiga vs Jardiance
Side-by-side cost comparison based on Medicare Part D data
Farxiga
Dapagliflozin
Manufactured by AstraZeneca
Jardiance
Empagliflozin
Manufactured by Boehringer Ingelheim
Jardiance costs 21% less per claim than Farxiga ($210.00 vs $266.00). A generic version of Jardiance is also available, which may reduce costs further.
Cost Per Claim
Medicare Spending
Beneficiaries
Annual Cost Per Patient
Full Comparison
| Metric | Farxiga | Jardiance |
|---|---|---|
| Avg Cost Per Claim | $266.00 | $210.00 |
| Total Medicare Spending | $3.0B | $3.9B |
| Total Beneficiaries | 1,340,000 | 2,150,000 |
| Total Claims | 11,240,000 | 18,760,000 |
| Annual Cost/Patient | $2,229.00 | $1,835.00 |
| Year-over-Year Change | +31.5% | +22.7% |
| Generic Available | Yes | Yes |
| Patent Expiration | Nov 13, 2025 | May 23, 2025 |
| Manufacturer | AstraZeneca | Boehringer Ingelheim |
| Condition | Diabetes | Diabetes |
| Generic Name | Dapagliflozin | Empagliflozin |
Farxiga vs Jardiance: What the Data Shows
Farxiga (Dapagliflozin) and Jardiance (Empagliflozin) are both used to treat diabetes. Based on Medicare Part D data, Jardiance costs $210.00 per claim, which is 21% less than Farxiga at $266.00 per claim.
Medicare spent $3.0B on Farxiga and $3.9B on Jardiance. In terms of patient reach, Jardiance serves more beneficiaries (2,150,000 vs 1,340,000).
Year-over-year spending changed +31.5% for Farxiga and +22.7% for Jardiance. Farxiga saw significant spending growth, suggesting increased utilization or price increases. Jardiance saw significant spending growth, suggesting increased utilization or price increases.
Both drugs have generic versions available. Patients should discuss generic alternatives with their pharmacist to reduce out-of-pocket costs.
Frequently Asked Questions
Jardiance is cheaper at $210.00 per claim, compared to $266.00 for Farxiga. That makes Jardiance about 21% less expensive per claim based on Medicare Part D data.
Yes, both Farxiga and Jardiance are used to treat diabetes. Your doctor can help determine which medication is more appropriate for your specific situation.
Both drugs have generic versions available. Generic Dapagliflozin and generic Empagliflozin can offer significant cost savings — typically 80-95% less than the brand name.
Medicare Part D spent $3.0B on Farxiga covering 1,340,000 beneficiaries, and $3.9B on Jardiance covering 2,150,000 beneficiaries.
Explore Further
Cost data reflects Medicare Part D spending and may not represent retail pharmacy prices. Average cost per claim represents the total drug cost (not patient out-of-pocket) divided by total claims. This comparison is informational only and should not replace medical advice.